Introduction to Long-Acting Injectable (LAI) Antipsychotics and Patient Selection
Webcast
0.5 Contact Hours Faculty
OVERVIEW
Introduction to Long-Acting Injectable (LAI) Antipsychotics and Patient Selection is organized by American Association of Psychiatric Pharmacists (AAPP).
Activity Dates: 05/31/2023 - 05/31/2026
Description:
This webinar reviews the signs, symptoms, and diagnostic criteria for serious mental illnesses; guideline recommendations for LAI antipsychotic use; the barriers, advantages, and disadvantages for the use of LAIs; and the role of the pharmacist in LAI administration in the pharmacy setting.
This is one of six modules in the Psychotropic LAI Training Program. Complete your complimentary registration now to access this module, 5 other ACPE approved modules, a LAI Pocket Guide, administration videos, and an Administrative Toolkit.
Learning Objectives:
- Describe the signs, symptoms, and diagnostic criteria for schizophrenia, bipolar disorder, and schizoaffective disorder.
- Identify advantages and disadvantages for the use of long-acting injectable (LAI) antipsychotics.
- Describe the role of the pharmacist in LAI antipsychotic administration in the pharmacy setting.
ACCREDITATION & CREDITS
Continuing Education Credit and Disclosures
ACPE Contact Hours: 0.5
ACPE Number: 0284-0000-23-021-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
TARGET AUDIENCE
PharmacistHealthcare ProfessionalsNursesSPECIALITIES
PsychiatryPatient and Family Centered Care
Quick Links